News about Global Pharma

Sterling Accuris Expands into Pharmaceutical and Analytical Testing

With this acquisition, Sterling Accuris has successfully expanded its range of services offered to fields such as pharmaceutical analytical testing.

Global Pharma | 13/12/2023 | By Manvi |  453

DifGen Pharmaceuticals Acquires KriGen Pharmaceuticals LLC

DifGen Pharmaceuticals Acquires KriGen Pharmaceuticals LLC - a Sterile Dosage Manufacturing Facility in North Carolina, US, Strengthening Its Position in Developing and Manufacturing Complex Differentiated Sterile Dosage Formulations

Global Pharma | 13/12/2023 | By Manvi |  1399

ACG Inspection Launch Cloud-Based Offering Addressing VRS Requirements Under DSCSA Regulations

The new system, which forms part of the ACG’s Inspections Life Sciences Cloud Service and Compliance Gateway, enables the automatic verification of saleable returns through product identifiers by routing requests and responses between stakeholders.

Global Pharma | 13/12/2023 | By Manvi |  551

Ferring and Pharmabiome Enter A Microbiome R&D Collaboration and Licensing Agreement

Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome are announcing a research & development collaboration to drive forward new microbiome-based biotherapeutics in the field of gastroenterology.

Global Pharma | 13/12/2023 | By Manvi |  520

Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility

This strategic investment will enhance radiopharmaceutical production capabilities at a key logistical hub to ensure the timely supply and delivery worldwide.

Global Pharma | 13/12/2023 | By Manvi |  345

PharmaKure and UiTM Collaborate for Advance Research in Alzheimer's Disease Diagnosis

The partnership is focused on advancing research initiatives on the use of machine learning tools to predict Alzheimer’s Disease using blood via academic-industry partnerships.

Global Pharma | 12/12/2023 | By Manvi |  621

Chinese Company to Set Up Pharmaceutical Ingredients Factory in BEPZA EZ

Chinese company Crescent Hi Tech Co. Ltd. is going to set up an ‘Active Pharmaceutical Ingredients (API)’ manufacturing industry in BEPZA Economic Zone.

Global Pharma | 12/12/2023 | By Manvi |  306

Vanda Pharmaceuticals Acquires US and Canadian Rights to PONVORY

Vanda Pharmaceuticals Inc. (Vanda) announced that it has acquired US and Canadian rights to PONVORY® (ponesimod) from Actelion Pharmaceuticals Ltd. (Janssen), a Johnson & Johnson Company.

Global Pharma | 12/12/2023 | By Manvi |  328

Natco Pharma Chennai Plant Operations Disrupted Due To Cyclone

After following the required step process and safety measures, the factory operations have been shut down temporarily, the drug firm said in a regulatory filing.

Global Pharma | 12/12/2023 | By Manvi |  562

AbelZeta Announces Agreement with AstraZeneca to Co-Develop a Novel GPC3 Armored CAR-T Therapy in China

C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II (TGFβRII) dominant negative armoring discovery platform, and is manufactured by AbelZeta in China.

Global Pharma | 12/12/2023 | By Manvi |  456